Originally established in 2002 as the Enterprise Venture Management Company, iMCI is a wholly owned subsidiary of i2E, Inc. and was created to operate as a venture capital investment firm targeting early stage technology and life sciences companies with high growth potential. i2E and iMCI have a rich, 22-year history of sourcing, vetting, and investing in early stage companies under both debt and equity structures.
Over the past two decades, i2E and iMCI have invested more than $77 million in 186 companies. In addition, iMCI has time-proven due-diligence and closing processes and provides a full range of portfolio management services including fund accounting, financial reporting, capital management, compliance and investor relations.
iMCI’s current equity portfolio represents a diverse group of industries with a concentration in software and life sciences.